Amplia Therapeutics Limited

ASX:ATX.AX

0.235 (AUD) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q2
Revenue 1.4072.0042.448-0.581.7691.2210.7630.6740.860.0340-00.051-0.0770.6570.6161.1821.4470.8170.0150.0150000
Cost of Revenue 0.0710.3310.0430.0440.0290.0020.00200000.0790.0770.0220.080.0750.1310.1140.1360.1190.11900.1670.1180.118
Gross Profit 1.3361.6742.405-0.6241.741.2190.7610.6730.860.034-0-0.079-0.026-0.10.5770.5411.0511.3320.681-0.104-0.1040-0.167-0.118-0.118
Gross Profit Ratio 0.950.8350.9821.0770.9840.9990.9980.99910.9880187.19-0.5111.2910.8780.8790.8890.9210.834-6.852-6.8520000
Reseach & Development Expenses 2.83.6112.1941.1583.5292.4711.3021.4610.750.7580.3130.5420.1361.1962.0293.1482.8883.3051.4421.0211.0210.3240.3240.3870.387
General & Administrative Expenses 1.2691.3891.2151.2050.9930.9040.7320.6340.5010.4060.4530.3940.4670.5380.8150.7310.7330.6280.6190.8010.8010.8730.8730.3630.363
Selling & Marketing Expenses 0.0670.040.1580.3880.1280.1650.050.3510.1770.2050.1220.1470.0970.0340.1580.1440.1530.1420.1290.070.0700.0520.1070.107
SG&A 1.3361.4291.3731.5941.1211.0690.7820.9850.6780.6110.5750.5410.5640.5751.0451.0491.6410.8520.8950.8010.801-0.2141.960.470.47
Other Expenses -0.041-0.023000000000000000000.0150.01500.02800
Operating Expenses 4.0955.0163.5672.7524.653.542.0842.4461.4281.370.8891.0840.7011.7133.0894.1834.5474.1772.8542.7152.7150.113.9781.291.29
Operating Income -2.759-3.342-3.61-2.796-4.679-3.542-2.085-2.446-1.429-1.37-0.889-1.163-0.727-1.813-2.512-3.642-3.496-2.844-2.173-2.699-2.699-2.044-2.044-1.515-1.515
Operating Income Ratio -1.961-1.668-1.4744.822-2.644-2.901-2.735-3.632-1.661-40.03202,756.372-14.28523.517-3.821-5.914-2.957-1.966-2.661-178.107-178.1070000
Total Other Income Expenses Net -0.055-2.0210.0320.0460.039-0.0010-0.1620.0570.0020.0040.0110.0080.0110.0010.048-0.0040.0360.0380.0810.081-0.203-0.232-0.179-0.179
Income Before Tax -2.814-5.364-3.578-2.751-4.64-3.542-2.085-2.444-1.371-1.368-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-2.619-2.619-2.248-2.247-1.694-1.694
Income Before Tax Ratio -2-2.676-1.4614.743-2.622-2.902-2.735-3.628-1.594-39.98102,730.227-14.10323.379-3.796-5.836-2.945-1.941-2.615-172.787-172.7870000
Income Tax Expense 0-1.989-2.4480.58-1.728-1.221-0.763-0.674-0.86-0.034-000000000-0.081-0.0810.0430.47800
Net Income -2.814-3.374-1.129-3.331-2.912-2.322-1.323-1.77-0.511-1.334-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-2.619-2.619-2.248-2.247-1.694-1.694
Net Income Ratio -2-1.683-0.4615.743-1.646-1.902-1.735-2.628-0.594-38.98102,730.227-14.10323.379-3.796-5.836-2.945-1.941-2.615-172.787-172.7870000
EPS -0.011-0.017-0.006-0.017-0.015-0.014-0.011-0.016-0.006-0.018-0.017-0.028-0.019-0.08-0.11-0.16-0.17-0.15-0.12-0.13-0.13-0.174-0.166-0.1-0.1
EPS Diluted -0.011-0.017-0.006-0.017-0.015-0.014-0.011-0.016-0.006-0.018-0.017-0.028-0.019-0.08-0.11-0.16-0.17-0.15-0.12-0.13-0.13-0.174-0.166-0.1-0.1
EBITDA -2.8-3.441-1.118-2.669-2.88-3.54-2.084-2.443-1.428-1.37-0.885-1.162-0.726-1.808-2.496-3.622-3.478-2.793-1.656-1.844-1.844-1.264-1.353-0.742-0.742
EBITDA Ratio -1.99-1.717-0.4574.602-1.628-2.9-2.733-3.627-1.661-40.0202,754.488-14.26923.454-3.797-5.882-2.942-1.93-2.028-121.689-121.6890000